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Abstract 
Significant heterogeneity across aetiologies, neurobiology, and clinical phenotypes have been 
observed in individuals with autism spectrum disorder (ASD). Neuroimaging-based neuroanatomical 
studies of ASD have often reported inconsistent findings which may, in part, be attributable to an 
insufficient understanding of the relationship between factors influencing clinical heterogeneity and their 
relationship to brain anatomy. To this end, we performed a large-scale examination of cortical 
morphometry in ASD, with a specific focus on the impact of three potential sources of heterogeneity: sex, 
age and full-scale intelligence (FIQ). To examine these potentially subtle relationships, we amassed a 
large multi-site dataset that was carefully quality controlled (yielding a final sample of 1327 from the 
initial dataset of 3145 magnetic resonance images; 491 individuals with ASD). Using a meta-analytic 
technique to account for inter-site differences, we identified greater cortical thickness in individuals with 
ASD relative to controls, in regions previously implicated in ASD, including the superior temporal gyrus 
and inferior frontal sulcus. Greater cortical thickness was observed to be sex-specific; further, cortical 
thickness differences were observed to be greater in younger individuals and in those with lower FIQ, and 
to be related to overall clinical severity. This work serves as an important step towards parsing factors that 
influence neuroanatomical heterogeneity in ASD and is a potential step towards establishing individual-
specific biomarkers.  
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Introduction 
Early brain overgrowth was one of the earliest neural phenotypes reported in autism spectrum 
disorder (ASD)1,2. However, subsequent studies examining advanced cortical phenotypes have reported 
diverse and conflicting neuroanatomical findings. For example, increases as well as decreases have been 
reported in both cortical thickness3–6 and surface area7–10. This may, in part, be attributable to factors that 
influence phenotypic heterogeneity in ASD, such as age, sex, and intelligence11–14. However, these 
potential sources of heterogeneity are commonly regressed out as nuisance variables in statistical 
modelling or not considered in ASD studies. In the face of limited sample sizes, previous studies have 
omitted females altogether5,15,16, or examined limited age ranges8,9,17–19, while others typically do not 
examine associations with intelligence. The limited studies considering these factors have observed that 
ASD-related atypical neuroanatomy varies greatly by age5,20–25, sex (see Lai et al26 for a review) and 
estimated intelligence27, suggesting a need to reconcile the association between factors that contribute to 
clinical heterogeneity and neuroanatomical differences. It is also possible that previous findings may be 
further confounded by biases in morphological estimates related to movement during image acquisition 
(particularly given the observation that neurotypical and males with ASD are most likely to move during 
scanning)28,29, and variations in the quality control of image processing outputs30. 
Here we sought to reconcile the impact of sex, age, and estimated intelligence on heterogeneity in 
ASD cortical morphology by performing a large-scale neuroimaging study using magnetic resonance 
imaging data acquired from multiple sources (initial dataset of 3145 subjects, 1327 subjects after rigorous 
quality control).   
Based on previous findings reported in the literature, we expected to see overall greater cortical 
thickness in individuals with ASD relative to neurotypical controls 5,31,32. Given known clinical, 
behavioural, and neuroanatomical sex differences in ASD, we expected these differences to differ in 
regional composition by sex 26,33,34. We also expected these differences to be more pronounced in younger 
5,35 and lower IQ individuals 17,27. 
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Methods 
Sample. Cross-sectional data included here were acquired from previous studies by the National Institute 
of Mental Health (USA), the Hospital for Sick Children (Canada), the Cambridge Family Study of 
Autism (UK), and the UK Medical Research Council Autism Imaging Multicentre Study (UK MRC-
AIMS). We also included publicly available data from the Autism Brain Imaging Data Exchange 
(ABIDE) I and II.36,37  
The total initial sample size amounts to 3145 individuals: 1415 individuals with ASD (1165 male/250 
female) and 1730 controls (1172 male/558 female), aged 2-65 years. See supplementary methods section 
S1 “Sample details” for imaging parameters and participant demographics. 
 
Quality control and site elimination. Rigorous quality control (QC) was performed by two independent 
raters (SB, and either ST or MMC) at both the level of the raw input images (for motion and scan quality), 
and on processed outputs (see supplementary methods section S2 “Quality control and site elimination”; 
supplementary figures S1 and S2). Sites with three or more individuals per sex and diagnostic group 
remaining after QC were included (final dataset of 1327 individuals; 491 individuals with ASD (362 
male/129 female) and 836 neurotypical controls (481 male/355 female) (supplementary tables S1 and S2). 
All analyses, unless otherwise indicated, were performed using this dataset of 1327 individuals.  
 
Image processing. All T1-weighted images were pre-processed using the minc-bpipe-library pre-
processing pipeline (https://github.com/CobraLab/minc-bpipe-library), and then submitted to the CIVET 
processing pipeline38 (version 1.1.12; Montreal Neurological Institute), to estimate cortical thickness, 
surface area, and volume. Image processing and quality control was standardised across all data, and 
conducted within a single laboratory. For details, see supplementary methods sections S3 “Image pre-
processing” and S4 “Image processing”.  
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Statistical analysis 
To account for differences in scanners, acquisitions, and sample characteristics, statistical 
analysis was conducted using a prospective meta-analytic technique, where each site is initially treated as 
an independent study and results are pooled to define significance (see van Erp et al.39). First, multiple 
linear regressions were conducted to derive per-site Cohen’s d effect sizes for the main effect of each 
variable of interest. An aggregate statistic representing all sites was derived by pooling effect sizes in a 
random-effects meta-analysis40,41 (metafor 2.0-0 package in R 3.4.0 ). For examples of statistical models 
employed, see supplementary methods section S5 “Statistical models used”. 
 
Code availability 
R code used to conduct the prospective meta-analyses described here is available from the 
corresponding authors upon request.  
 
Case-control comparisons: global measures 
Differences in mean cortical thickness (CT), total surface area (SA), cortical volume (CV), total 
grey matter (GM), total white matter (WM) and total brain volume (TBV) were compared between 
individuals with ASD and controls by examining the main effect of diagnosis, while including age (linear 
term) and sex in the model. Results were Bonferroni corrected with p<0.008 (based on 6 tests) being 
considered significant. GM and WM analyses were reanalyzed while controlling for TBV, to determine if 
these were differentially affected when accounting for global measures. 
 
Case-control comparisons: vertex-wise analysis 
Regional alterations in CT and SA were examined using the same meta-analytic technique and 
model described above for global measures, but extended to a vertex-wise level (81,924 vertices across 
the brain), and corrected for multiple comparisons using the false discovery rate [FDR]42. To control for 
multiple comparisons both across vertices and across the various analyses done, p-values from all vertices 
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of all main analyses were pooled (including each interval of the age- and FIQ-centred analyses described 
in the subsequent sections), and a 5% FDR threshold was used to control for multiple comparison across 
all statistical tests conducted. This stringent FDR correction was applied separately for cortical thickness 
and surface area analyses. 
Case-control comparisons were also examined using a mixed-effects model with site as a random 
factor to determine if our results diverge from previous large-scale studies that used this methodology 
(e.g. van Rooij et al6). 
 
Heterogeneity-focused analyses: Importance of sex, age and FIQ  
To assess the significance of sex, age and FIQ in our vertex-wise analysis of cortical alterations, 
we fitted two models for each variable: one including the variable of interest (i.e. sex, age, or FIQ), plus 
an interaction term between that variable and diagnosis, and the other without the variable of interest, or 
the interaction, in the model. Please see supplementary methods section S5 “Statistical models used” for 
details. We then used Akaike information criterion43 (AIC, representing the best model fit) to determine 
the importance of the variable at each vertex, within each site separately. At each vertex, we determined 
the number of sites for which each model was shown to be the best fit, and calculated a weighted average 
(based on site size) to determine the best model, on average, at that vertex, taking into account all sites.   
Based on the AIC comparison of the models, sex, age, and FIQ were demonstrated to be 
important explanatory variables at a substantial proportion of vertices across the brain for both CT and 
SA, motivating our further examination of these factors and their impact on cortical alterations in ASD 
(see supplementary figure S3 and S4).  
 
Sex-focused analyses  
Sex specific patterns were examined using the case-control analysis described above separately in 
males and females (for global and vertex-wise measures), with diagnosis and age (linear term) included in 
the model. 
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Age-focused analyses  
Given variable reporting of best-fit trajectories in ASD and typical neurodevelopment in 
general30,44, we tested the best model fit between linear, quadratic and cubic models of age (all models 
also included diagnosis, each age term, interaction between diagnosis and each age term, and sex; see 
supplementary methods section S5 for statistical models used). To do this, at each vertex, the minimum 
AIC was determined for each site, and a weighted average across sites was calculated per vertex, as 
described above. 
The AIC for age revealed the linear model to be the best fit at most sites (range across vertices: 
22-100% of sites) across most of the cortex for both cortical thickness (supplementary figure S5A) and 
surface area (supplementary figure S6A).  
Next, an age-centered analysis was used to examine age-dependent changes in patterns of vertex-
wise CT and SA alterations by centering age at intervals of 2 years, accounting for age as a linear term. 
This allows us to illustrate the differential effects on cortical thickness at different ages, and allows 
interpretation of group differences at the centered age interval. Essentially, this provides a “snapshot” of 
the groups’ regression lines at that interval, without having to split the dataset into age ranges, thereby 
maximising power, and case-control differences were examined at each age interval5,45. This was done by 
calculating the per-site Cohen’s d effect size for the main effect of diagnosis from each model (each age 
interval), and pooling these effect sizes in the random effects meta-analysis in the same manner as the 
case-control comparisons. 
 
FIQ-focused analyses 
The best model fit for the FIQ analyses was tested in the same way as the age analyses described 
above: the best model fit was tested between linear, quadratic and cubic models of FIQ (all models also 
included diagnosis, each FIQ term, interaction between diagnosis and each FIQ term, age and sex). 
 The AIC for FIQ revealed the linear model to be the best fit at most sites (range across vertices: 
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24-100% of sites) across most of the cortex for cortical thickness (supplementary figure S5B) and surface 
area (supplementary figure S6B).  
An FIQ-centered analysis was performed in the same fashion as the age-centered analysis, with 
FIQ centered at intervals of 10 points, and using a linear term for FIQ. Results are examined at intervals 
of FIQ=80 and above, as there are very few controls with an FIQ<80. As FIQ data were not available for 
all individuals, this analysis was performed on a slightly smaller subset of 1214 individuals.   
 
Associations between cortical thickness and ASD symptoms/characteristics 
 
As consistent autistic symptom or characteristics measures were not available across all sites, 
analyses were performed on subsets of individuals who had the same measures, as in previous studies6,46. 
We chose the measures which had the largest number of individuals available, which included the ADOS-2 
Calibrated Severity Scores (CSS)47 to examine overall symptom severity (N= 279; also conducted 
separately in males [N=224] and females[N=55]), the ADOS-G reciprocal social interaction domain score, 
communication domain score, and restricted, repetitive behaviour [RRB] domain score (module 4; N=151), 
and the ADOS-2 RRB domain score and social affect domain score (module 3; N=143), all in individuals 
with ASD only. In both ASD and control individuals, we examined associations between CT and scores of 
the Social Responsiveness Scale (SRS; N=413) and Autism Spectrum Quotient48 (AQ; N=171), as well as 
their interaction with diagnosis.   
These analyses were conducted using a meta-regression technique. See supplementary methods 
section S6 “Associations between cortical thickness and ASD severity and symptoms” for meta-analysis 
details and subset sample characteristics. 
Finally, we also performed a separate analysis to examine the potential effects of comorbid 
diagnoses on cortical alterations related to ASD. We repeated the case-control analysis excluding data 
from individuals with comorbid diagnoses (limiting our analyses to sites with this type of data recorded; 
resulting in a dataset of  N=519; 144 ASD/375 Controls).  
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Case-control, sex-stratified and age centered analyses including FIQ in the model  
Based on the results of the AIC analysis assessing the importance of FIQ as an explanatory 
variable, we examined the diagnosis, age-centered and sex-stratified analyses including FIQ in the model. 
This was done in the subset of individuals for whom FIQ data were available (N=1214). For these 
analyses, FDR correction was conducted across all analyses (including all age intervals) together, but 
separately from the main set of analyses. 
 
Impact of quality control (QC) 
We examined the impact of quality control on both the neuroanatomy and demographics of our 
sample (see supplementary methods section S7 “Quality control analysis”).  
 
Power calculation  
We used G*Power version 3.1.9.4, to determined the minimum detectable effect sizes given our 
sample size of 491 individuals with ASD and 836 controls. At a power level of 0.8 and a significant 
threshold of 0.05 (two-tailed), we determined we would be have the statistical power to detect effect sizes 
of 0.1463 and greater. However, this is based on a simple multiple linear regression analysis that pools all 
data together, ignoring the differences between sites, and not accounting for this in the analysis. It is 
unclear how the meta-analytic technique employed here would affect these estimates.  
 
Results 
Results of case-control comparisons and sex-focused analysis are presented in figure 1, the age-
focused analysis in figure 2, the FIQ-focused analysis in figure 3, and symptom/severity-focused analysis 
in figure 4. 
 
Greater cortical volume and mean and regional cortical thickness in ASD 
We observed significantly greater CV (p<0.008; Cohen’s d=0.17) and mean CT (p<0.0001; 
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Cohen’s d=0.22) and a trend towards enlarged TBV (p<0.05; Cohen’s d = 0.11) in individuals with ASD 
(figure 1A). No differences were observed in total SA, WM or GM. When controlling for TBV, both GM 
and WM remain non-significant, however WM seemed to be slightly more affected, changing from 
p=0.1, to p=0.9 when controlling for TBV, whereas GM was barely affected (p=0.25 in original analysis, 
and p=0.24 when controlling for TBV). 
In the vertex-wise analysis, regional group differences of CT (greater CT in ASD compared to 
controls) were observed in the inferior frontal and prefrontal cortex, superior temporal, postcentral, and 
posterior cingulate gyri and precuneus, bilaterally, surviving 5% FDR (peak Cohen’s d = 0.32). Effect 
sizes showed some variability by site, however were largely positive (figures 1B and 1D; supplementary 
figure S7). The mixed effects model yielded similar results to the meta-analytic approach, however the 
results were less significant and over a smaller proportion of the cortex (supplementary figure S8). No 
significant differences were observed in SA.  
 
Sex-specific cortical alterations  
ASD males had significantly greater CV (p<0.008; Cohen’s d=0.19) and mean CT (p<0.008; 
Cohen’s d=0.21) compared to male controls (supplementary figure S9). WM volume trended towards 
being greater in ASD males relative to controls (p<0.05; Cohen’s d=0.18). No differences in total SA or 
GM volume were observed. In females with ASD, mean CT trended towards being greater compared to 
controls (p<0.05; Cohen’s d=0.21). No differences were observed in TBV, total SA, CV, GM or WM in 
the females (supplementary figure S10).  
Both males and females with ASD presented with regions of significantly greater CT relative to 
controls, surviving 5% FDR, however, the observed patterns of CT differences were distinct between 
males and females (figure 1E and 1F). In ASD males, regions of greater CT were observed in bilateral 
superior temporal, inferior frontal, and right precentral gyri (peak Cohen’s d = 0.39). In ASD females, 
these differences were observed in bilateral prefrontal and occipital cortices, and left posterior parietal 
cortex and pre- and postcentral gyri (peak Cohen’s d = 0.45). Sex-specific effect sizes were overall 
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stronger than in the combined sample, and larger effect sizes were observed in the females compared to 
males (supplementary figures S11 and S12). 
In the both males and females, for cortical thickness, the mixed effects model yielded similar but 
less diffuse results, and only survived 5% FDR in the left hemisphere (for both, see supplementary figure 
S13).  
No significant differences in SA were observed in the males or females (meta-analytic model 
used for both).  
 
Subtle age-specific cortical alterations 
In the age-centered analyses, subtle but significant group differences in CT were maximal in 
childhood (8-10 years), with individuals with ASD presenting demonstrating greater CT relative to 
controls in small regions of the cortex. Figure 2 shows differences between individuals with ASD and 
controls at age intervals of four years, accounting for age using a linear model. Foci of significance were 
most apparent in the age range of 8-12 years, but the linear fits suggested steadily larger effect sizes for 
diagnosis on CT as one moves towards younger ages. Between the ages of 6-14 years, regions of 
significantly greater CT were observed primarily in lateral temporal and frontal regions, and the posterior 
cingulate cortex. After 12-14 years, less difference is observed between groups, and these differences 
were observed only in medial prefrontal regions.  
In the age centered surface area analysis, no significant differences in SA were observed at any 
age interval.  
 
 
 
 FIQ  
Individuals with ASD with lower FIQ were observed to have much greater and more widespread 
differences in CT relative to controls than those with higher FIQ (figure 3), spanning large regions of the 
frontal, temporal and occipital cortices. Foci of significance were most apparent in the FIQ range of 100-
100, but the linear fits suggested steadily larger effect sizes for diagnosis on CT as one moves towards 
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lower FIQ. At FIQ of 120 only minimal significant group differences in CT are observed. Higher than 
this, no significant differences are seen. 
In the FIQ centered surface area analysis, no significant differences in SA were observed at any 
FIQ interval.  
 
Associations between cortical thickness and ASD symptoms/characteristics  
A significant, positive correlation between CT and ADOS-2 CSS was observed in ASD 
individuals, primarily in the right hemisphere. This relationship was observed in regions in which 
individuals with ASD presented with significantly greater CT relative to controls, including the right 
superior temporal gyrus and inferior frontal sulcus, right orbitofrontal cortex, and bilateral posterior 
cingulate cortices. Furthermore, motivated by our findings of sex-specific regions of CT alterations in 
subjects with ASD, we explored the relationship between CT and CSS in males and females separately.  
In the female sample, we observed a significant positive relationship between CT and severity, primarily 
in prefrontal and temporal regions. Conversely, in the males, only very minimal regions showed this 
significant relationship, despite the much larger sample size compared to the females (figure 4). Males 
and females in this sample did not differ significantly in severity or FIQ.  
No significant associations were observed between the SRS or AQ and CT. Only very minimal 
significant associations were observed for ADOS domain scores with CT, in very small cortical regions. 
Please see supplementary results section S7 and supplementary figures S14 and S15 “Associations 
between neuroanatomy and ASD symptoms/characteristics” for details. 
Based on our analysis of the potential impact of comorbidities, including only individuals with 
ASD with no comorbid features does not seem to change the spatial extents of our results, but does impact 
the number of vertices surviving 5% FDR, and increases the overall effect size. Please see supplementary 
results section S8 and supplementary figure S16 for details. 
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Case-control, sex-stratified and age-centered analyses including FIQ in the model 
Including FIQ in the model did not substantially alter the results for the diagnosis main effect, 
sex-stratified analyses, or age-centered analyses. Please see supplementary results section S9, and 
supplementary figures S17-S20.    
 
 
Discussion  
 In this study we use a large dataset that has been strictly quality controlled and analyzed using 
harmonized image processing and statistical methods in order to study variation in cortical anatomy in 
ASD. Our results demonstrate greater cortical thickness in widespread cortical regions in individuals with 
ASD, primarily in the frontal and superior temporal cortex, as well as the precuneus and posterior 
cingulate cortices. Cortical alterations were observed to be differentially impacted by sex, age, and FIQ. 
Greater CT was observed in largely different regions between males and females, with females 
demonstrating potentially greater magnitude of cortical thickness alterations than males, relative to same-
sex controls. Group differences were greatest in childhood, and differences lessen after early adulthood. 
Alterations were observed in largest regions and were more significant in individuals with FIQ of 80-110, 
with almost no significant group differences observed in individuals with FIQ of 120 and higher. In ASD 
individuals, greater CT was positively correlated with symptom severity measured by ADOS-2 CSS, in 
regions which also showed greater CT relative to controls, and these correlations were stronger, and seen 
in distinct regions, in females compared to males. 
Greater total brain volume (TBV) in very young children with ASD is one of the most 
consistently reported findings in the ASD neuroimaging literature49–51, and some studies show that this 
larger brain volume persists into adolescence52. Mechanisms potentially underlying increased TBV 
include increased neurogenesis, decreased synaptic pruning and neuronal cell death, and abnormal 
myelination53. Our results suggest that the larger TBV phenotype observed in ASD can also be 
recapitulated at levels of local and global cortical thickness (though here we only observed greater TBV 
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in ASD at a trend level). Increased cell proliferation in the ventricular zone during development has been 
suggested as underlying abnormalities in the number and width of cortical columns (resulting in increased 
cortical surface area), as well as increased neuronal density54 (resulting in increased cortical thickness). 
Both cortical column abnormalities and increased neuronal density have both been reported in ASD55, 
thus it is unclear why we do not observe the alterations in surface area in individuals with ASD reported 
by other studies7–9. It is also unclear how quality control may impact results (see below for further 
discussion on this). Thus this relationship warrants further investigation. Deficiencies in synaptic 
pruning56, which begins in early life and continues into adolescence, have also been proposed as 
underlying the greater cortical thickness observed in ASD57. This is supported by studies reporting 
reduced synaptic pruning during development in children with ASD58, and could explain the differences 
that persist into adulthood, as observed here.  
It should be noted that other factors can affect cortical thickness measurements; for example, 
altered cortical myelination or reduced integrity of the gray-white matter boundary, potentially resulting 
from deficits in neuronal migration during early development. Specifically, this blurring of the cortical 
interface has been demonstrated in individuals with ASD in both histological post-mortem59 and in-vivo 
neuroimaging studies60,61, and could potentially lead to inaccuracies in cortical thickness estimates due to 
misplacement of the cortical boundary, with apparent increases in cortical thickness. 
Previous studies8,10,51 have reported very early expansion of the cortical surface and increased 
surface area in young children (2-5 years) and infants (6-24 months) with ASD, and suggest this may 
drive the early brain overgrowth that has been observed in ASD. In keeping with our results, other studies 
have found no group differences in SA in preschoolers62, or children and adolescents24. However, lower 
SA has been observed in children with ASD aged 9-20 years, normalising in adulthood 9, as well as in a 
sample of male adults with ASD7. There is evidence that cortical thickness peaks around one or two years 
of age, and gradually decline thereafter into adolescence63, whereas surface area develops rapidly in the 
first year of life, and continues to gradually expand into late childhood or adolescence, before 
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declining63,64. Therefore it is possible that the early increases in surface area in ASD observed in previous 
studies normalise after this period of rapid development, and thus were not captured in our sample, which 
has only very few individuals between the ages of 2-5. 
With this large dataset, we hoped to reconcile some of the inconsistencies reported in the 
literature with regard to cortical phenotypes of ASD. While many other neuroimaging studies of ASD 
have reported greater cortical thickness values5,15,31, others have reported lower thickness65, or no 
differences9. Our findings of greater CT in ASD are largely in agreement with other large-scale 
neuroimaging studies, including studies using the ABIDE dataset5,15,16,66 and recent findings by the 
ENIGMA consortium6. However, the recent ENIGMA study, in addition to greater CT in ASD in the 
frontal and posterior cingulate cortices, also reports significantly less CT in ASD in the temporal and 
parahippocampal cortices. We found no regions of significantly lower CT values; conversely, we 
observed greater CT, in multiple temporal regions. Methodological differences may account for the 
disparity between our results and those of the ENIGMA study, as well as others reporting decreased CT in 
ASD. These differences include our rigorous quality control (more discussion on this below), the analysis 
of region-specific differences using the vertex-wise extension of the prospective meta-analysis technique 
(instead of the regions of interest approach in the ENIGMA study), differences in image processing 
pipelines, and differences in sample characteristics (despite some overlap between our and the ENIGMA 
sample [ABIDE sample and ~150 controls from the Toronto sample]). Interestingly, the ENIGMA study 
found that the mixed-effect models strategy yielded more significant results than the meta-analytic 
technique, whereas we found the opposite. It is unclear how the choice of statistical method interacts with 
these other factors, however, we believe that the meta-analytic model better deals with the possible 
confounding variables and variability between sites, and that the mixed effects model may be less 
sensitive to capturing small effect sizes through the noise introduced by this variability. 
Other studies using the ABIDE dataset have likewise found abnormalities in cortical thickness in 
ASD, in regions overlapping with our results, but of varying magnitude and direction5,15,16. Most 
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consistent between these studies is the observation of greater CT in individuals with ASD in the superior 
temporal gyrus, as well as frontal regions. However, it should be noted that most of these studies examine 
males only, and thus are more appropriately interpreted in comparison to our male-specific results.  
Quality control likely greatly contributes to the inconsistencies in the literature; many studies do 
not describe their QC procedures in detail, rendering it difficult to assess the impact that motion or 
inaccurate segmentation may have on reported results. In our study, particular attention was given to 
motion artefact at the level of the raw input images, as in-scanner motion is known to cause apparent 
cortical thinning due to blurring of the grey-white matter boundary28,67. Thus, inadequate QC could lead 
to results of greater CT in individual with ASD, a population likely to move while being scanned, being 
attenuated or obscured by this effect. Importantly, in our sample, when no or minimal quality control was 
implemented, CT differences (greater in ASD) that were observed in the quality controlled sample were 
greatly attenuated. Additionally, regions of decreased CT in the bilateral temporal poles and left 
orbitofrontal cortex were also observed in individuals with ASD (supplementary figure S21). Decreased 
CT in these regions has previously been reported to be associated with motion29,67, and these results 
highlight the potential for motion to confound results. 
In addition to the issue of QC, it is often unclear to what extent case-control differences reported 
in the literature are influenced by factors contributing to the heterogeneity observed, such as age, sex, FIQ 
and severity68. Thus, another primary objective of this work was to begin to parse this heterogeneity 
observed in ASD, and determine to what extent these factors influence the reported diagnostic differences 
in neuroanatomy observed in previous studies, and the variability in these results. While these factors 
have been demonstrated to impact the neuroanatomical alterations in ASD17,22,26, many studies do not take 
them into account when examining case-control differences.  
In particular, the issue of sex differences in ASD has been receiving more attention recently, yet 
still studies examining neuroanatomical sex differences are rare, and have largely been underpowered due 
to small samples sizes of females with ASD26. Of existing studies examining sex differences in CT 
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specifically, results are varied: one such study found a sex-by-diagnosis interaction, with lower CT in 
ASD females, but greater CT in ASD males34, 34 report no difference6,33. Even with our large sample and 
proportion of females with ASD (362 males and 129 females with ASD), we do not detect a significant 
sex by diagnosis interaction. However, when stratifying by sex, we demonstrate both qualitatively and 
quantitatively distinct diagnostic effects in males and females, as well as a sex-specific relationship 
between ASD symptom severity and cortical thickness. Our overall case-control results much more 
closely reflect those of the male-only findings, suggesting the female differences (observed in different 
regions, and with larger effect sizes) are obscured due to the small sample. Interestingly, the relationship 
between CT and ASD symptom severity seemed to be driven primarily by the females. This is in spite of 
the fact that in this sample, males and females do not differ significantly in ASD symptom severity or 
FIQ; suggesting that females perhaps need more substantial  neuroanatomical alterations to result in the 
same level of clinical presentation as in males (in keeping with the female protective hypothesis69,70). 
These results highlight the importance of taking biological sex into account when studying ASD, as well 
as the urgent need for studies examining neuroanatomical sex differences in ASD in larger samples. 
Age has been a significant contributor to the heterogeneity observed in ASD. Results of studies 
examining different age ranges of ASD, in particular in those with small sample sizes, are often 
conflicting or inconsistent. Recent large scale studies examining wide age ranges that have attempted to 
reconcile these inconsistencies have reported cortical thickness differences in childhood and early 
adolescence, followed by normalisation of group differences later in life5,6,66. While we cannot strictly 
make inferences about cortical development from our cross-sectional dataset, here, we seem to 
recapitulate these results to an extent, though the results observed in our age-centred analysis are subtle. 
This possible attenuation and eventual disappearance of diagnostic group differences in adolescence and 
adulthood could be the result of accelerated cortical thinning in ASD after an initial period of overgrowth, 
as has been observed in previous longitudinal samples5,22 as well as post-mortem studies71. We also 
demonstrated a linear model to be the best fit for the majority of our dataset, across most of the cortex, as 
opposed to the curvilinear trajectories that have been reported by other studies5,6 . This may be due, in 
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part, to the meta-analytic technique we chose to employ, which necessitated conducting the model fit on a 
per site basis, as some smaller sites may lack the power to model higher order trajectories. Improved 
quality control (QC) in our study may also play a role, as a recent study demonstrated that after strict QC, 
previously observed higher order trajectories were mostly replaced by linear effects30. While some early 
general population studies reported a peak in CT in late childhood followed by a decline72,73,  more recent 
studies, including those using generalised additive mixed models (GAMM)74,75, have reported a 
monotonic decrease in CT from around two years of age22,30,44,76,77. Our findings, though cross-sectional, 
seem to support this reported linear decline in CT, rather than a peak later in childhood. Taken together, 
our findings may help further clarify the recent changes in our understanding of neurotypical and atypical 
cortical developmental trajectories72,73 as these models continue to evolve in relation to the greater 
awareness of potential age-related biases related to motion and image processing quality control. 
However, given that our data are not longitudinal, and the inclusion of limited number of adults, these 
results should be interpreted with these caveats in mind. Larger, longitudinal studies will be necessary to 
confirm these findings. 
Few studies have examined the potential moderating effects of IQ on the neuroanatomy of ASD, 
though there is some evidence suggesting that individuals with a diagnosis of Asperger’s syndrome (with 
average or above average IQ) present with milder neuroanatomical atypicalities compared with lower IQ 
individuals27,78. Despite our sample being skewed to the cognitively higher functioning end of the 
spectrum, our results seem to align with these findings as we observed greater alterations in the lower FIQ 
part of our sample. Further, our observation of an inverse relationship between CT and FIQ in individuals 
with ASD, with the opposite or no relationship in controls, is aligned with previous studies of ASD17 as 
well as in typically developing individuals.79 Shaw et al.80 also demonstrated that IQ is differentially 
associated with CT in children compared to adults; future larger-scale work should examine three way 
relationship between IQ, CT, and age in the context of ASD, as well as the extent to which group 
differences observed may be attributable to lower intellectual functioning rather than simply ASD 
diagnosis. 
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 As ADOS versions and modules were not consistent across sites, we could not directly test the 
relations between region-specific cortical alterations and specific ADOS symptom domains in the whole 
sample. However, the positive relationship between ADOS-2 CSS and CT observed in a subset of 
individuals with ASD, in regions where case-control differences were observed, suggests a functional 
relevance of these cortical alterations. Some of the strongest group differences in both the overall sample 
and in the symptom-based analyses were observed in the superior temporal gyrus (STG) and inferior 
frontal gyrus (IFG) and might reflect the social communication deficits that are characteristic of ASD.81–84  
Interestingly, the IFG and STG were also the regions where the strongest case-control differences in CT 
were observed in males, but not in females. 
 The results presented here should be interpreted with respect to several limitations.  Firstly, in 
order to amass the significant amount of data presented here, we were required to pool already collected 
data from multiple sites. The lack of standardization across sites of MRI acquisition, inclusion criteria, 
and clinical assessments between sites should be considered. While the meta-analytic statistics used pool 
common effect sizes across sites, the impact of this lack of standardization will certainly have an impact 
on our results.  The lack of standardised measures across sites made examination of heterogeneity 
associated with specific ASD symptoms challenging. As a result, the impact of important factors such as 
socioeconomic status and parental education (which were not available for any of our sample) could not 
be ascertained. Similarly, we could not directly assess the impact of specific comorbid diagnoses (which 
were collected and coded inconsistently between sites); however, based on the results of our analysis 
including only individuals with no comorbidities, the inclusion of individuals with ASD with comorbid 
features did not seem to substantially impact our results, though this may have added further variability 
and attenuated the effect of group differences observed. More targeted investigations into the relationship 
between common ASD-specific comorbidities and the clinical and neurobiological heterogeneity 
commonly observed in ASD is necessary. Please see supplementary tables S3 and S4 for details on clinical 
and demographic data available per site. The statistical analysis method itself may also, in turn, be limited 
in its ability to detect small effects within each site, as well as curvilinear relationship with age or FIQ in 
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the smaller samples.  
In addition, there are two considerations which would have improved our ability to better 
understand factors impacting heterogeneity. The first is the absence of genetic data. While ASD is highly 
heritable, it has been associated with a diverse number of risk genes85–87 and rare copy number 
variants.88,89 These genotypes have been observed to impact the heterogeneity of ASD and require further 
consideration. The second is the use of longitudinal data to truly model intra-individual change over time 
to better define alterations in neuroanatomical trajectories.45,90 It is possible, given the large sample size 
used, that we have partially overcome this limitation given that our results are consistent with at least one 
large, longitudinal study examining cortical development in ASD.22  Nonetheless, further investigation 
with large longitudinal samples that include males and females are clearly needed.  
Finally, further consideration of the demographics of our sample is needed when interpreting our 
findings. This includes being cautious regarding interpretation of findings in the part of the sample >30 
years old, as this represents a smaller subset of the study cohort. Second, the unbalanced male/female 
distribution requires further consideration. It is likely that we are only detecting the largest effect size 
differences between ASD and control females and there are likely smaller effects that we are 
underpowered to detect. Finally, individuals excluded due to QC were younger, had lower IQ and higher 
severity scores, and included a higher proportion of male and ASD individuals; thus biasing and further 
skewing our sample towards higher IQ individuals (see supplementary table S5). We acknowledge that 
smaller studies might not have the option of excluding such a large proportion of their data. However, in 
light of the potential contribution of motion and data quality to inconsistencies in the literature, there are 
certain steps that should be taken to ensure proper quality, and thus reliability, of data. These include the 
use of prospective motion correction techniques such as vNavs volumetric navigators91, the recruitment of 
larger samples with the knowledge that there may be a large proportion of data that could not be used in 
statistical analyses, to book sufficient scanner time so as to allow re-scanning where necessary, and, in the 
case of small samples, to augment the sample using publicly available or collaborator data for replication 
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purposes. The potential exploration and subsequent use of motion/quality scores as confounding variables 
in analyses could also be considered92,93. Our thorough and rigorous manual QC was initiated and 
performed prior to the availability of these kinds of methods, thus we have not included these methods in 
our analysis. Nonetheless, we believe that the final QC used in this sample is extremely thorough.  
Our findings address limitations in the literature regarding cortical neuroanatomy in ASD by 
combining multiple datasets. Our sample of 1327 individuals allowed us to detect significant group 
differences in the whole sample, as well as to examine potential sources of heterogeneity in relation to 
sex, age and FIQ, and their impact on cortical alterations in ASD. These findings highlight the importance 
of taking into account factors contributing to the phenotypic heterogeneity in ASD when examining the 
neuroanatomy in a supervised manner68, which could further our research of the neurobiology of ASD. 
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Figure captions 
Figure 1. Case-control comparisons. Individuals with ASD presented with overall greater cortical 
volume and mean CT, and a trend towards greater total brain volume, as well as regionally specific 
differences in CT. These group differences are observed in sex-specific patterns of regional involvement, 
and are of a larger magnitude in the females. A. Cohen’s d effect sizes for case-control comparisons of 
cortical volume (CV), total grey matter (GM), mean cortical thickness (CT), total brain volume (TBV), 
total surface area (SA) and total white matter (WM) (* denotes p < 0.008; error bars represent 95% 
confidence intervals). Positive effect sizes denote greater values in individuals with ASD compared to 
controls. Significantly greater CV (p<0.008) and mean CT (p<0.0001), are observed in individuals with 
ASD. B. Forest plot of Cohen’s d effect sizes of mean CT per site. C. Significant vertex-wise group 
differences in CT across all subjects, shown at an FDR threshold of 5% (top), and effect size maps 
(bottom). Individuals with ASD show greater CT relative to controls.  D. Forest plot showing effect sizes 
per site at a peak vertex in the right superior temporal gyrus. E. Significant vertex-wise group differences 
in CT in females, shown at an FDR threshold of 5% (top) and effect size maps (bottom). Females with 
ASD show greater CT relative to controls, primarily in left prefrontal, parietal and occipital regions. 
Effect sizes in females are greater than those seen in males. F. Significant vertex-wise group differences 
in CT in males, shown at an FDR threshold of 5%  (top) and effect size maps (bottom). Males with ASD 
show greater CT relative to controls, primarily in bilateral inferior frontal and superior temporal regions.  
 
Figure 2. Age-centered analysis. Main effect of diagnosis shown at 4 year intervals, using a linear model 
for age, shown at 5% FDR up until the age of 32, after which no significant differences are seen. Only 
minimal group differences are seen in the linear model, primarily in right superior temporal and inferior 
frontal regions. CT at a peak vertex in the left inferior frontal sulcus is plotted against age (bottom).  
 
Figure 3. FIQ-centered analysis. Main effect of diagnosis at intervals of 10 FIQ points, using a linear 
model for FIQ (shown at 5% FDR), from an FIQ of 80, up until the age of 130, after which no significant 
differences are seen. Maximal differences were observed around an FIQ of 100. CT at a peak vertex in the 
right occipital lobe is plotted against FIQ (bottom).  
 
Figure 4. Relation between CT and ADOS-CSS. Relationship between ADOS-2 calibrated severity 
scores (CSS) and CT in individuals with ASD, shown at a peak vertex in the inferior frontal sulcus (IFS). 
ADOS-2 severity was positively correlated with CT, primarily in the right hemisphere, in regions which 
show significant increases in individuals with ASD relative to controls. Correlations between CT and CSS 
were observed in distinct regions between males and females. In the female sample, there was a 
significant positive relationship between CT and severity, primarily in prefrontal and temporal regions. In 
the males, only very minimal regions showed this significant relationship, observed in the superior 
temporal gyrus and temporal pole. Shown at 5% FDR.   
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